Skip to main content
. Author manuscript; available in PMC: 2013 Sep 10.
Published in final edited form as: BJU Int. 2010 Dec;106(11):1805–1811. doi: 10.1111/j.1464-410X.2010.09327.x

Table 3.

Univariate analysis evaluating baseline patient characteristics

Characteristic No. of patients Median OS, years Hazard ratio (95% CI) P
RRM1 expression:
 high 42 2.1 0.94 0.81
 low 42 2.0 (0.57, 1.54)
Age, years:
 < 70 43 5.4 2.19 0.002
 ≥ 70 41 1.3 (1.32, 3.63)
Gender:
 male 63 2.0 0.95 0.86
 female 21 2.0 (0.55, 1.66)
T stage:
 T2 28 4.0 0.68
(0.40, 1.15)
0.15
 T3 36 1.4 1.11
(0.67, 1.84)
0.68
 T4 20 1.2 1.46
(0.82, 2.57)
0.2
Nodal involvement:
 positive 26 1.8 0.89 0.66
 negative 58 2.3 (0.52, 1.51)
Stage group
 II 25 4.3 0.62
(0.36, 1.08)
0.091
 III 32 1.2 1.34
(0.80, 2.23)
0.26
 IV 27 1.8 1.20
(0.71, 2.02)
0.51